411 related articles for article (PubMed ID: 33953366)
21. Eculizumab in secondary atypical haemolytic uraemic syndrome.
Cavero T; Rabasco C; López A; Román E; Ávila A; Sevillano Á; Huerta A; Rojas-Rivera J; Fuentes C; Blasco M; Jarque A; García A; Mendizabal S; Gavela E; Macía M; Quintana LF; María Romera A; Borrego J; Arjona E; Espinosa M; Portolés J; Gracia-Iguacel C; González-Parra E; Aljama P; Morales E; Cao M; Rodríguez de Córdoba S; Praga M
Nephrol Dial Transplant; 2017 Mar; 32(3):466-474. PubMed ID: 28339660
[TBL] [Abstract][Full Text] [Related]
22. Advances in our understanding of the pathogenesis of hemolytic uremic syndromes.
Bowen EE; Coward RJ
Am J Physiol Renal Physiol; 2018 Mar; 314(3):F454-F461. PubMed ID: 29167171
[TBL] [Abstract][Full Text] [Related]
23. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
[TBL] [Abstract][Full Text] [Related]
24. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
[TBL] [Abstract][Full Text] [Related]
25. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.
Le Clech A; Simon-Tillaux N; Provôt F; Delmas Y; Vieira-Martins P; Limou S; Halimi JM; Le Quintrec M; Lebourg L; Grangé S; Karras A; Ribes D; Jourde-Chiche N; Rondeau E; Frémeaux-Bacchi V; Fakhouri F
Kidney Int; 2019 Jun; 95(6):1443-1452. PubMed ID: 30982675
[TBL] [Abstract][Full Text] [Related]
26. Atypical haemolytic uraemic syndrome: a case of rare genetic mutation.
Sangeetha G; Jayaraj J; Ganesan S; Puttagunta S
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330731
[TBL] [Abstract][Full Text] [Related]
27. [Atypical HUS caused by complement-related abnormalities].
Yoshida Y; Matsumoto M
Rinsho Ketsueki; 2015 Feb; 56(2):185-93. PubMed ID: 25765799
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.
Bu F; Maga T; Meyer NC; Wang K; Thomas CP; Nester CM; Smith RJ
J Am Soc Nephrol; 2014 Jan; 25(1):55-64. PubMed ID: 24029428
[TBL] [Abstract][Full Text] [Related]
29. Thrombomodulin and Endothelial Dysfunction: A Disease-Modifier Shared between Malignant Hypertension and Atypical Hemolytic Uremic Syndrome.
Demeulenaere M; Devreese K; Vanbelleghem H; De Zaeytijd J; Vande Walle J; Van Biesen W; Van Laecke S
Nephron; 2018; 140(1):63-73. PubMed ID: 29940557
[TBL] [Abstract][Full Text] [Related]
30. Where are we with haemolytic uremic syndrome?
Cavero T; Alonso M
Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703
[TBL] [Abstract][Full Text] [Related]
31. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
[TBL] [Abstract][Full Text] [Related]
32. Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies.
Maisons V; Duval A; Mesnard L; Frimat M; Fakhouri F; Grangé S; Servais A; Cartery C; Fauchier L; Coppo P; Titeca-Beauport D; Fage N; Delmas Y; Quérard AH; Seret G; Bobot M; Le Quintrec M; Ville S; von Tokarski F; Chauvet S; Wynckel A; Martins M; Schurder J; Barbet C; Sautenet B; Gatault P; Caillard S; Vuiblet V; Halimi JM;
Kidney Int; 2024 May; 105(5):1100-1112. PubMed ID: 38431217
[TBL] [Abstract][Full Text] [Related]
33. Eculizumab treatment of thrombotic microangiopathy in a patient with ulcerative colitis.
Øzbay LA
Clin J Gastroenterol; 2020 Jun; 13(3):344-348. PubMed ID: 31612381
[TBL] [Abstract][Full Text] [Related]
34. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.
Asif A; Nayer A; Haas CS
J Nephrol; 2017 Jun; 30(3):347-362. PubMed ID: 27848226
[TBL] [Abstract][Full Text] [Related]
35. Atypical hemolytic uremic syndrome.
Loirat C; Frémeaux-Bacchi V
Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
[TBL] [Abstract][Full Text] [Related]
36. Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy.
Korzycka J; Pawłowicz-Szlarska E; Masajtis-Zagajewska A; Nowicki M
Am J Case Rep; 2022 Oct; 23():e936565. PubMed ID: 36306276
[TBL] [Abstract][Full Text] [Related]
37. Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab.
Gately R; San A; Kurtkoti J; Parnham A
Nephrology (Carlton); 2017 Feb; 22 Suppl 1():32-35. PubMed ID: 28176475
[TBL] [Abstract][Full Text] [Related]
38. Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation.
Stea ED; Skerka C; Accetturo M; Pesce F; Wiech T; Hartman A; Pontrelli P; Conserva F; Castellano G; Zipfel PF; Gesualdo L
Front Immunol; 2022; 13():1008294. PubMed ID: 36451836
[TBL] [Abstract][Full Text] [Related]
39. Anti-factor H antibody and its role in atypical hemolytic uremic syndrome.
Raina R; Mangat G; Hong G; Shah R; Nair N; Abboud B; Bagga S; Sethi SK
Front Immunol; 2022; 13():931210. PubMed ID: 36091034
[TBL] [Abstract][Full Text] [Related]
40. [Atypical hemolytic uremic syndrome].
Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
